Virtual CME Program
Understanding and Improving Vaccine Hesitancy in African American PatientsEpisode 7: Bridging the Gap: Conversations with Dr. Hall
This session will provide an overview of the health disparities related to the acceptance of vaccines among racial and ethnic groups in the US. We will discuss the historical basis for some of the apprehensions that exist in the African American community. We will look at conspiracy theories that are circulated regarding vaccines and discuss ways to reassure patients about the safety and any real risks. Finally, we will discuss best practices related to COVID-19 vaccine discussions with patients who are hesitant to accept.
- Review vaccine acceptance trends in the US for among racial and ethnic minorities
- Discuss the historical basis for mistrust of preventive measures among African Americans including conspiracy theories which may perpetuate this mistrust
- Describe best practices in the discussion of the COVID-19 vaccine and ways to improve acceptance
Gregory L. Hall, MD
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH
Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH
Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH
Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Gregory L. Hall, MD: No relevant financial relationships disclosed.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions? If you have questions about this activity, please email email@example.com or call (877) 477-4633.